SCHEMBL7368324

SCHEMBL7368324

CNC(C(N)=O)C(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
CHRM2 P08172 1/20 0.44
ADRA1A P35348 1/20 0.44
RGS12 O14924 1/20 0.44
GLA P06280 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ALOX12 P18054 1/20 0.44
ADRA2C P18825 1/20 0.44
NFKB1 P19838 1/20 0.44
HTR2A P28223 1/20 0.44
CYP2C19 P33261 1/20 0.44
THPO P40225 1/20 0.44
GNAI1 P63096 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KMT2A Q03164 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31370476 0.85 MME (0.50) CHRM2ADRA1ARGS12GLACYP3A4
SCHEMBL27555772 0.85 MME (0.50) CHRM2ADRA1ARGS12GLACYP3A4
SCHEMBL31688764 0.85 MME (0.50) CHRM2ADRA1ARGS12GLACYP3A4
SCHEMBL27555773 0.85 MME (0.50) CHRM2ADRA1ARGS12GLACYP3A4
SCHEMBL31369902 0.85 MME (0.50) CHRM2ADRA1ARGS12GLACYP3A4
SCHEMBL27873367 0.81 ADRA2C (0.53) CHRM2ADRA1ARGS12GLACYP3A4
SCHEMBL3266526 0.81 MME (0.44) ALOX5CHRM2ADRA1ARGS12GLA
SCHEMBL14958859 0.78 TDP1 (0.41) ALOX5HSD17B10KMT2AMEN1LMNA
SCHEMBL23177815 0.77 ALDH1A1 (0.61) CYP3A4CYP2D6TSHRHSD17B10KMT2A
SCHEMBL23177694 0.77 ALDH1A1 (0.61) CYP3A4CYP2D6TSHRHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1093463-A1 A METHOD FOR PREPARING A COMPOUND WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 2001-04-25 EP disclosed
WO-1999064456-A1 A METHOD FOR PREPARING A COMPOUND WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1999-12-16 WO disclosed
EP-0941115-A1 USE OF GROWTH HORMONE OR A GROWTH HORMONE SECRETAGOGUE FOR PROMOTING BONE FORMATION NOVO NORDISK A/S (DK) 1999-09-15 EP disclosed
EP-0907374-A1 GROWTH HORMONE COMPONENT AND BONE ANTI-RESORPTIVE AGENT IN CYCLIC (COHERENCE) TREATMENT OF OSTEOPOROSIS NOVO NORDISK A/S (DK) 1999-04-14 EP disclosed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 EP disclosed
WO-1998019699-A1 USE OF GROWTH HORMONE OR A GROWTH HORMONE SECRETAGOGUE FOR PROMOTING BONE FORMATION NOVO NORDISK A/S (DK) 1998-05-14 WO disclosed
WO-1997046252-A1 GROWTH HORMONE COMPONENT AND BONE ANTI-RESORPTIVE AGENT IN CYCLIC (COHERENCE) TREATMENT OF OSTEOPOROSIS NOVO NORDISK A/S (DK) 1997-12-11 WO disclosed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 WO disclosed